Mergers & AcquisitionsBy The Online Investor Staff, updated Wed., Feb. 26, 6:09 PM
|This Slide: #88 of 100|
Slide #88. Zealand Pharma A/S — Valeritas Holdings, Inc.
Zealand Pharma A/S
Valeritas Holdings, Inc. (NASDAQ:VLRX)
Zealand Pharma A/S (CVR-no. 20 04 50 78), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces a bid to acquire substantially all assets from Valeritas Holdings, Inc. (NASDAQ: VLRX) for a total cash consideration of $23 million and the assumption of certain liabilities related to the ongoing business, pursuant to the terms of the "stalking horse" asset purchase agreement entered into with Valeritas (as described below).
Strong Buy (4.00 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite